Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
EconTalk
English - January 30, 2023 11:30 - 1 hour - 63.6 MB - ★★★★★ - 4K ratingsCourses Education Science Social Sciences economics business books interviews history ethics Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Dwayne Betts on Beauty, Prison, and Redaction
Next Episode: Sam Harris on Meditation, Mindfulness, and Morality
Oncologist and epidemiologist Vinay Prasad argues that too many very expensive drugs get approved by the FDA that have very limited impact on the lives of patients. Prasad explains the incentives that distort the current system. The general problem, he explains to EconTalk host Russ Roberts, is the death of duty--too many players in the health care landscape and elsewhere stay quiet or do the wrong thing in order to serve themselves.